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Introduction
The healing of skin wounds involves several different tis-
sues and cell lineages, including fibroblasts.1 It involves 
re-epithelialization, which includes the replication and 
movement of epidermal cells to make new tissue, followed 
by formation and contraction of granulation tissue consist-
ing of small vessels, fibroblasts, myofibroblasts and 
inflammatory cells.1–3 Fibroblasts are responsible for the 
production and maintenance of the extracellular matrix 
(ECM) of connective tissues and appear to be activated by 
trauma.4
ECM is mainly responsible for the mechanical strength 
of tissues and also provides support for cells.5,6 It contains 
glycoproteins and glycosaminoglycans (GaGs) reinforced 
by collagen fibrils.5–7 Different tissues contain different 
GaGs and different collagens in varying proportions, to 
provide the required mechanical properties.6,8 Additionally, 
interactions between cells and the ECM are important for 
the function of a living tissue.6,7,9
In previous studies pulsed low-intensity ultrasound 
(PLIUS) was used to stimulate collagen production by 3T3 
mouse fibroblasts10 and calf chondrocytes;11 this study 
investigates whether PLIUS can be used to stimulate 
human dermal fibroblast (HDF) activity. HDFs have been 
used to treat sun-damaged skin12,13 and for foetal skin 
repair.14 PLIUS stimulation has been shown 
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This study evaluated the effect of pulsed low-intensity ultrasound on cell proliferation, collagen production and 
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to effect proliferation and matrix deposition of human 
chondrocytes15,16 and to increase GaG synthesis in a human 
nucleus pulposus cell line.17 It has also been suggested that 
PLIUS could improve wound healing in people suffering 
from diabetes mellitus, venous insufficiency and excessive 
pressure.18 However, the effect of PLIUS on HDF cells 
encapsulated in alginate has not been reported before. 
Encapsulation mimics the environment of a cell sur-
rounded by ECM in a living organism.19 Alginate is a plant 
polysaccharide whose both chemical structure and physi-
cal properties resemble those of the GaGs in ECM; there-
fore, both alginate and collagen (the other main 
macromolecular component of ECM) have been used pre-
viously for encapsulation.20–22
Materials and methods
Materials
Alginate, Dulbecco’s modified Eagle medium (DMEM), 
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bro-
mide (MTT) powder, Alcian blue dye, chloramine T, 
1,9-dimethylmethylene blue dye (DMB), p-dimethylamin-
obenzaldehyde (p-DMBA) and a DNAQF DNA 
Quantification Kit were purchased from Sigma–Aldrich 
(Poole, Dorset, United Kingdom). Foetal calf serum was 
purchased from PAA Laboratories (Farnborough, 
Hampshire, United Kingdom). All other materials were 
obtained from Sigma–Aldrich.
HDF cells
Fibroblasts were from a commercially available primary 
cell line (adult HDF; HPA Culture Collections, Porton 
Down, Salisbury, United Kingdom). Cells were main-
tained in DMEM supplemented with calf serum (10 v/v%), 
penicillin or streptomycin (1 v/v%), l-glutamine (2.4 v/v%) 
and 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulphonic 
acid (HEPES; 2.4 v/v%). Cells were stored in sterile condi-
tions at 37°C and 5% CO2, and the growth medium was 
replaced every 3 days.
Cell encapsulation
Cells were detached from the flask in which they were cul-
tured with trypsin (0.05%) and EDTA (0.2 g/L) and resus-
pended in DMEM. Viable cell numbers were determined 
by staining with trypan blue and counting in a haemocy-
tometer, to quantify the growth properties of the cells.23 
After this, 2% sodium alginate solutions, made with dou-
ble distilled water, were seeded with cells at a density of 
2 × 106 cells/mL.24 The cell suspension was transferred to 
the wells in 12-well plates and incubated in a bath of sterile 
CaCl2 solution for 2 h.25 The resulting discs of calcium 
alginate with encapsulated cells were washed three times 
with sterile phosphate-buffered saline solution (PBS) and 
transferred to six-well plate; each well contained supple-
mented DMEM (5 mL) which was refreshed every 3 days.24
Cell encapsulation supplemented with growth 
factors
Cell were encapsulated and prepared in the same way as in 
the previous subsection, except that the cultures were sup-
plemented with 50 µg/mL ascorbic acid26 and 2.5 ng/mL 
transforming growth factor beta-1(TGF-β1)27 to encourage 
ECM production.
Ultrasound treatment
A Sonopuls 491 (Enraf-Nonius, Rotterdam, Amsterdam) 
ultrasound source was used. Its transducer was immersed 
in a water bath filled with deionized water maintained at 
37°C28 and treated with a solution (Sigma Clean Water 
bath) to keep it free from bacterial and fungal growth. The 
deionized water was changed every week. The six-well 
plate containing constructs to be treated was placed on top 
of the transducer; the control group was maintained in the 
same conditions without being exposed to ultrasound. The 
ultrasound stimulation was performed 5 min every day for 
10 days at the frequency of 1 MHz and an intensity of 
0.2 W/cm2 with a 20% duty cycle (i.e. 20 pulses were emit-
ted in 1 s, so that each pulse had a duration of 0.05 s).10 
Treated and control samples were analysed, after 4, 6, 8 
and 10 days, to determine cell numbers, collagen content 
and GaG content; at each time period, results for each 
analysis were obtained for three different samples.
Cell content
Samples were freeze-dried for 2 days and then digested in 
papain solution (1 mL).29 Total cell numbers were deter-
mined by a Hoechst assay using a DNAQF DNA 
Quantification Kit.30 Hoechst 33258 dye (200 µL) was added 
to samples (10 µL) in a 96-well plate. Fluorescence (excited 
at a wavelength of 360 nm) was measured using a spectro-
photometer (Promega GloMax; Promega, Southampton, 
United Kingdom) at a wavelength of 460 nm, at ambient 
temperature. The total cell numbers were obtained from a 
calibration curve constructed using HDF cells.
Hydroxyproline assay
Hydroxyproline content provides a measure of collagen 
content and was determined using a method described 
previously31,32 but with some modification, as described 
below. In this method, 50 µL samples that had been 
digested with papain were hydrolysed in 6 M hydrochloric 
acid (HCl) at 110°C for 20 h and then kept in a vacuum 
dessicator overnight to allow evaporation of the remaining 
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HCl. The samples were then reconstituted with 200 µL 
assay buffer (5 g/L citric acid (monohydrate), 12 g/L 
sodium acetate (trihydrate), 3.4 g/L sodium hydroxide and 
1.2 mL/L glacial acetic acid in distilled water, pH 6.0).31 
The reconstituted samples were then mixed with activated 
charcoal and left in ambient conditions for 30 min. They 
were then centrifuged at 14,000 r/min for 6 min. A total of 
50 µL of the clear samples were then mixed with 
Chloramine T solution (50 µL, 62 mM) and then incubated 
at room temperature for 15 min to allow oxidation to occur. 
They were then mixed with 50 µL p-DMBA solution32 and 
incubated at 60°C for 30 min. The absorbance of the sam-
ples was measured using a microplate reader (Promega 
GloMax; Promega) at a wavelength of 550 nm. The 
hydroxyproline content of the samples were determined 
from a regression line of absorbance plotted against con-
centration (0–1 µg/mL) for trans-4-hydroxy-l-proline.
GaG assay
The GaG content was quantified by a previously described 
method10,33 with a slight modification. Briefly, 40 µL of 
papain digested samples were added to 250 µL DMB dye at 
pH 1.5. This was done to minimize the reaction of the dye 
with the alginate.34 DMB dye can be influenced by binding 
of carboxyl groups of alginate to the DMB dye at pH 3.0.33 
Absorbances were measured at a wavelength of 600 nm in 
the dark to maintain the stable condition of the dye35 using a 
spectrophotometer (Promega GloMax; Promega). The GaG 
content of the samples was determined from a standard 
solution of whale chondroitin 6-sulphate (0–100 µg/mL).
Alcian blue staining
Alginate gels containing cells were stained using Alcian 
blue dye.36,37 The encapsulated cells were fixed with 10% 
formalin for 20 min and then washed with PBS. The gels 
were then stained with Alcian blue dye for 48 h (0.05% 
Alcian blue in 3% acetic acid, pH 1.5 and 0.3 M MgCl2).36 
The alginate–cells were then washed sequentially with 3% 
acetic acid, 3% acetic acid and 25% ethanol, 3% acetic 
acid and 50% ethanol and 70% ethanol. The encapsulated 
cells were observed using a light microscope (AxioLab; 
Zeiss, Oberkochen, Germany).36,37
Sample preparation for scanning electron 
microscopy
HDF cells encapsulated in an alginate disc were fixed with 
2.5% glutaraldehyde in 0.1 M phosphate buffer for 1 h. 
After this, the samples were dehydrated in alcohol (50%, 
70%, 90% and 100%) twice for 15 min for each alcohol 
change. Then, the samples were dried using critical point 
CO2, and the dried samples were mounted on a stub and 
coated with platinum. The samples were then viewed using 
a scanning electron microscope (SEM; Philips XL30 
ESEM FEG; Philips, Eindhoven, the Netherlands).
Statistical analysis
A Shapiro–Wilk test38 for normality was performed on all 
the data presented here. The data were then analysed using 
the independent t-test for normal data and the Mann–
Whitney test for non-normal data.38 Differences were con-
sidered to be significant if the probability p < 0.05.
Results
Total cell number
Hoechst 33258 dye was used to quantify cell number since 
it is known to selectively stain double-stranded DNA for 
both live and dead cells as little as 5–10 ng in isolated 
nuclei, cells extracts and papain digestion samples;39,40 this 
is directly proportional to the total number of cells within 
a sample and is not influenced by the metabolic variations 
caused by encapsulation and PLIUS treatment. Using this 
assay, it was shown that samples treated with PLIUS con-
tained higher cell numbers than the untreated samples in a 
period of 4–10 days (Figure 1(a)). However, this apparent 
Figure 1. Cell proliferation for control (Ctrl) and treated 
(PLIUS) groups (a) not supplemented with growth factors and 
(b) supplemented with growth factors (ascorbic acid and TGF-
β1). Results that are significantly different (p < 0.05) are marked 
with an asterisk.
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difference was only statistically significant after 4 and 
8 days. Figure 1(b) shows that when the samples are sup-
plemented with TGF-β1, this apparent trend disappears; 
indeed the only statistically significant difference (after 
6 days) shows fewer cells in the samples treated with 
PLIUS than in the control samples and suggests that the 
growth factor treatment has changed cell phenotype.
However, comparison of Figure 1(a) and (b) shows that 
PLIUS treatment alone is far more effective in increasing 
cell numbers than is supplementation with ascorbic acid 
and TGF-β1. After 10 days, the number of cells when 
growth factor was added was 63 × 105 ± 7.5, which is com-
parable to the number (87 × 105 ± 13) in control samples 
with no growth factors and no PLIUS treatment. However, 
the samples treated with PLIUS alone contain many more 
cells (150 × 105 ± 40).
Collagen production
Figure 2(a) shows a significant increase in hydroxyproline 
and, hence, collagen production throughout the 4- to 10-day 
period. However, Figure 2(b) shows that when the samples 
were supplemented with growth factors, no consistent trend 
is apparent, and PLIUS appears to significantly affect col-
lagen production only at 6 days.
GaG production
Figure 3(a) shows an apparent decrease in GaG content 
during the 4- to 10-day period with PLIUS having no sta-
tistically significant effect on the results. Similar results 
are shown in Figure 3(b) when the growth factors were 
added in the samples. Although PLIUS appears to signifi-
cantly increase the GaG content at 8 days, there is no con-
sistent pattern, and this single result is inconclusive.
GaG location in the encapsulated HDF cells was exam-
ined by Alcian blue staining. After 8 days as shown in 
Figure 4, the stained sample showed halos of Alcian blue 
around the cells indicating that they had begun to produce 
GaGs. Alcian blue staining revealed the formation of GaGs 
for the whole experimental period. Although the results 
were qualitative, they showed no difference in GaG pro-
duction for control and treated groups.
SEM result
As shown in Figure 5, the application of PLIUS to the cells 
did not appear to result in damage when compared to the 
Figure 2. Hydroxyproline (Hyp) content for control (Ctrl) 
and treated (PLIUS) groups (a) not supplemented with 
growth factors and (b) supplemented with growth factors 
(ascorbic acid and TGF-β1). Results that are significantly 
different (p < 0.05) are marked with an asterisk; results that 
are significant at a higher level (p < 0.01) are marked with two 
asterisks.
Figure 3. Glycosaminoglycan (GaG) content for control (Ctrl) 
and treated (PLIUS) groups (a) not supplemented with growth 
factors and (b) supplemented with growth factors (ascorbic 
acid and TGF-β1). Results that are significantly different 
(p < 0.05) are marked with an asterisk.
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control group. These results were comparable to those for 
the 3T3 cells.10 The cells did not spread, into a fibroblast-
like shape, presumably because alginate does not contain 
moieties that allow for the attachment of cells. Interestingly, 
however, this does not appear to be a detrimental effect 
since the HDF cells maintained their viability and prolifer-
ated in culture (Figure 1(a) and (b)).
Discussion
Many previous studies have shown a positive effect of 
therapeutic ultrasound, at different doses, on human fibro-
blasts.18,28,41–45 However, previous studies were all per-
formed on monolayers of cells. In our previous report, we 
showed that therapeutic ultrasound increases collagen and 
GaG production for encapsulated mouse fibroblasts 
(3T3).10 The continuation study, described here, was 
intended to determine the effect of PLIUS on HDF cells 
maintained in three-dimensional (3D) culture.
The results for HDF cells show that PLIUS may lead to 
an increase in cell numbers but only in the absence of 
TGF-β1 and ascorbic acid. This finding is supported by 
previous studies that showed that therapeutic ultrasound 
increased the cell numbers for human fibroblasts.28,43,44 As 
discussed in the previous study,10 PLIUS did not stimulate 
the proliferation of 3T3 mouse fibroblasts. However, in the 
case of HDF cells, the results presented in this study show 
that PLIUS did stimulate cell proliferation but only in the 
absence of TGF-β1 and ascorbic acid. This is likely 
because although the PLIUS does provide a mechanical 
stimulus that can enhance proliferation, TGF-β1 promoted 
differentiation to a myofibroblastic phenotype. The myofi-
broblastic phenotype is characterized by the expression of 
α-smooth muscle actin (SMA) and an associated charac-
teristic change in morphology to a stellate shape. Since the 
cells, however, were not attached to the alginate matrix, it 
was impossible to make a judgement on phenotype. 
Myofibroblasts are, however, responsible for the deposi-
tion of ECM proteins such as collagen I in wounds, 
although it should be noted that the deposition of matrix is 
usually at the expense of the rate of cell proliferation. 
Indeed, Doan et al.28 stated that if a cell number increase is 
observed with PLIUS treatment, this may actually reduce 
the extent to which the cells are able to deposit ECM. 
However, the data presented here were not totally in agree-
ment with the results of Doan et al.28 since we demon-
strated that an increase in cell number was associated with 
an increase in collagen deposition.
As shown in Figure 2(a), the hydroxyproline content and, 
hence, the collagen content increased for up to 10 days of 
treatment, but when the cells were supplemented with TGF-
β1 and ascorbic acid (Figure 2(b)), there was no consistent 
Figure 4. Alcian blue staining of human dermal fibroblasts encapsulated in alginate after 8 days in culture for (a) the control group 
in the absence of growth factors, (b) the treated group in the absence of growth factors, (c) the control group in the presence 
of growth factors, (d) the treated group in the presence of growth factors and (e) the alginate disc only. A blue dark region 
surrounding the cells shows the presence of GaG (arrow). All micrographs are at the same magnification.
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effect. TGF-β1 functions by accelerating differentiation to 
matrix producing myofibroblast cells.26,27,46–50 Ascorbic acid 
has been shown to increase ECM synthesis in chondrocyte 
cells, human fibroblast and human aortic smooth muscle 
cells,46,47,49 while TGF β-1 was effective in upregulating the 
synthesis of collagen in human fibroblast cells, rabbit mar-
row mesenchymal stem cells and neonatal rat smooth muscle 
cells.26,27,48,50 However, the results presented here are incon-
sistent with these published observations. This may be due to 
the type of cells and scaffold being used and the culture con-
ditions used to maintain the cells.26,27,46–50 Indeed, an article 
by Smith et al.51 demonstrated that when encapsulated in 
alginate, although cells can be shown to generate collagen 
type I, the influence of the highly charged alginate matrix 
inhibits collagen fibrillization within the gel structure, mean-
ing that defective fibrils pass through the hydrogel matrix 
and into the surrounding matrix. This collagen is very diffi-
cult to quantify using chemical assays and has been observed 
to form on the surface of the culture media. Collagen that is 
accrued within these matrices seems to be deposited around 
the encapsulated cells, and where proliferation has occurred 
within pockets in the gel structure, increased quantities of 
collagen deposition have been observed. It is possible that 
the PLIUS stimulated proliferation within the gel enhanced 
collagen deposition in pockets within the gel, but the inhib-
ited proliferation caused by myofibroblastic differentiation 
in the TGF-β1- and ascorbic acid–treated specimens meant 
that collagen production was maintained at a consistent level. 
Indeed, when one considers the quantity of collagen depos-
ited within the matrix, it is directly related to cell number. 
This is clearly a very important consideration when design-
ing a conditioning regime for generating collagenous 3D tis-
sue constructs.
Treatment with PLIUS alone appeared to have no effect 
on GaG production (Figure 3(a)) and only shows a signifi-
cant results (3.2 mg/construct) when used in conjunction 
with TGF-β1 and ascorbic acid (Figure 3(b)). While one 
might expect that TGF-β1 treatment might upregulate 
GaG production to a certain extent, the addition of ascor-
bic acid would be expected to have no effect since it is a 
cofactor in the intercellular processing of collagen prior to 
secretion. Furthermore, the pattern of the data here is also 
Figure 5. Scanning electron micrographs of a cross-section of alginate disc showing human dermal fibroblasts encapsulated in 
alginate after 10 days in culture for (a) the control group in the absence of growth factors, (b) the treated group in the absence of 
growth factors, (c) the control group in the presence of growth factors, (d) the treated group in the presence of growth factors and 
(e) the alginate disc only. A blue dark region surrounding the cells shows the presence of GaG (arrow). Examples of viable cells are 
indicated with an arrow.
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same as that of 3T3 mouse fibroblast cells in a previous 
study.10 This result could be explained by dye binding to 
the carboxyl groups in the alginate.33 Nevertheless, Alcian 
blue staining (Figure 4) showed that the HDF or alginate 
construct also produced the GaGs with or without the 
growth factor supplements.
SEM micrographs show that the cells encapsulated 
within the alginate disc did not adhere to the surrounding 
molecules (Figure 5). Previous studies also show that 
cells did not adhere to alginate52,53 unless it was modified 
by coupling with RGD peptides that mediate cell adhe-
sion.52,54 Previous studies mentioned that the floating or 
aggregation of cells could be caused by the negatively 
charged guluronate and mannuronate residues in the algi-
nate molecule.22,53,55 Alginate is highly porous material 
and is likely to entrap the cells within the matrix rather 
than the cells adhering to the alginate molecular chains.22 
The lack of cell adhesion did not prevent the HDFs pro-
liferating, even though the cells did not attach to the algi-
nate (Figures 1(a), (b) and 5). This was supported by a 
previous study showing that MC3T3 cells also prolifer-
ate, and the differentiation is not modified when the cells 
were encapsulated within alginate beads.56 Moreover, 
hydroxyproline content also increased as a result of 
PLIUS treatment alone (Figure 2(a)) but not when it was 
combined with TGF-β1 and ascorbic acid (Figure 2(b)).
This shows that the cells produce collagen when treated 
with PLIUS. When treated with both PLIUS and growth 
factors, the cells were involved less in cellular division 
(Figure 1(b)) rather than in collagen production (Figure 
2(b)). Nonetheless, PLIUS alone performed better in 
enhancing cells proliferation (Figure 1(a)) and collagen 
production (Figure 2(a)).
It is noteworthy that under the conditions used in these 
experiments, PLIUS treatment did not show any deleteri-
ous effect on the cells. This is consistent with recent work 
in which PLIUS with a frequency of 1 MHz and intensities 
in the range of 0.75–1 mW/cm2 with 10%–20% duty cycles 
did not inhibit cell viability and proliferation.28,43,44,57,58 
There is a possibility that the PLIUS conditions used in 
this experiment can be beneficial in wound healing;18 how-
ever, growth factors would be present in the healing 
wound. Given our unexpected finding that PLIUS is less 
effective in the presence of growth factors, this finding 
warrants further research.
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